ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1816 • ACR Convergence 2023

    Hyperuricemia – Especially “Metabolic Hyperuricemia” – Is Independently Associated with Higher Risk of Fatty Liver

    Janis Timsans1, Jenni Kauppi1, Hannu Kautiainen2 and Markku Kauppi3, 1Päijät-Häme Central Hospital, Lahti, Finland, 2University of Helsinki, Folkhälsan Research Center, Helsinki, Finland, 3University of Helsinki, Helsinki, Finland

    Background/Purpose: Elevated serum uric acid (SUA) level is rather prevalent in the general population, and it is associated with numerous comorbidities and mortality. Etiology of…
  • Abstract Number: 2035 • ACR Convergence 2023

    Intimate Partner Violence Is Associated with a Poorer Health-Related Quality of Life (HR-QoL) in Women with Systemic Lupus Erythematous

    Emmanuel Campos-Tinajero1, Griselda Serna-Peña2, Jorge A. Esquivel-Valerio1, Rodrigo J. Castillo-de la Garza3, Gisela García Arellano4, Pablo Gamez-Siller1, Estefania Aguilar-Rivera5, Patricia L. Gonzalez-Garcia1 and Dionicio A. Galarza-Delgado6, 1Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 2Universidad Autónoma de Nuevo León, Guadalupe, Mexico, 3Universidad Autónoma de Nuevo León, Monterrey, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 5Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico, 6Hospital Universitario UANL, Monterrey, Mexico

    Background/Purpose: Systemic lupus erythematosus (SLE) is an inflammatory, multisystemic, chronic disease more prevalent in women and can significantly impact health-related quality of life (HRQoL).1 Sociodemographic…
  • Abstract Number: 2378 • ACR Convergence 2023

    Longitudinal Trajectories of Renal Function in ANCA-Associated Vasculitis: Findings from the Expanded Mass General Brigham Cohort

    Jennifer Hanberg1, Claire Cook1, Xiaoqing Fu1, Hyon K. Choi2, Yuqing Zhang3 and Zachary Wallace4, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital and Harvard Medical School, Lexington, MA, 3Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 4Massachusetts General Hospital, Newton, MA

    Background/Purpose: ANCA-associated vasculitis (AAV) commonly causes renal damage, leading to a spectrum of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Quantitative descriptions of…
  • Abstract Number: 2564 • ACR Convergence 2023

    The Effectiveness of a Fourth Dose of COVID-19 mRNA Vaccine in Patients with Systemic Autoimmune Rheumatic Diseases Using Immunomodulators: An Emulated Target Trial

    Jennifer Hanberg1, Xiaoqing Fu1, Xiaosong Wang2, Naomi Patel1, Yumeko Kawano2, Abigail Schiff2, Emily Kowalski2, Claire Cook1, Kathleen Vanni2, Krishan Guzzo1, Grace Qian2, Katarina Bade3, Alene Saavedra2, Rathnam Venkat2, Shruthi Srivatsan1, Yuqing Zhang4, Jeffrey Sparks5 and Zachary Wallace6, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 5Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 6Massachusetts General Hospital, Newton, MA

    Background/Purpose: Many patients with systemic autoimmune rheumatic diseases (SARDs) using immunomodulators have blunted humoral responses to COVID-19 vaccines. As such, the initial mRNA vaccine series…
  • Abstract Number: 098 • 2023 Pediatric Rheumatology Symposium

    Characterization of Pulmonary Nodules in Juvenile-onset Systemic Sclerosis: A Single Center Case-Series

    Jonathan Li1, Franziska Rosser1, Sameh Tadros1 and Kathryn Torok2, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Given the high prevalence of intestinal lung disease (ILD) in systemic sclerosis (SSc) and the low sensitivity of pulmonary function testing for diagnosing ILD,…
  • Abstract Number: 0059 • ACR Convergence 2022

    Healthcare Resource Utilization and Costs of Management of Lupus Nephritis in Adult and Juvenile Patients with Systemic Lupus Erythematosus

    Kenneth Kalunian1, Janice Ma2, Konrad Pisarczyk2, Richard Leff3, Kiruthi Palaniswamy4 and Li Long4, 1University of California San Diego, La Jolla, CA, 2Maple Health Group, LLC, New York, NY, 3Kezar Life Sciences, South San Francisco, CA, 4Kezar Life Sciences, Inc., South San Francisco, CA

    Background/Purpose: Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE), which develops in about one-third of SLE patients within…
  • Abstract Number: 0475 • ACR Convergence 2022

    Whole-country and Regional Incidences of Giant Cell Arteritis in French Continental and Overseas Territories: A Nationwide Database Analysis

    Hubert De Boysson1, Lydia GUITTET2, Damiano CERASUOLO2, Rémy MORELLO2, Samuel DESHAYES2 and Achille Aouba1, 1Department of Internal Medicine, UR4650 PSIR, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France, 2Caen University Hospital, Caen, France

    Background/Purpose: The incidence rate of giant cell arteritis (GCA) is poorly studied in France. Therefore, we conducted a national hospital database study to assess the…
  • Abstract Number: 0718 • ACR Convergence 2022

    Biomarkers Predict Worsening of Lumbar Spine Degeneration and Low Back Pain: The Johnston County Osteoarthritis Project

    Adam Goode1, Rebecca Cleveland2, Virginia Kraus1, Steve George1, Kenneth Taylor3, Todd Schwartz4, Jordan Renner4, Janet Huebner1 and Yvonne Golightly5, 1Duke University, Durham, NC, 2University of North Carolina, Chapel Hill, NC, 3Duke University School of Medicine, Durham, NC, 4University of North Carolina- Chapel Hill, Chapel Hill, NC, 5University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Disc space narrowing (DSN) at the intervertebral disc and vertebral osteophyte (OST) formation are two potential sources of nociceptive lower back pain (LBP). The…
  • Abstract Number: 1011 • ACR Convergence 2022

    Trends in Fracture Rates Among Veterans with Ankylosing Spondylitis

    Sali Merjanah1, Jean Liew1, John Bihn2, Nathanael Fillmore2, Nhan Do3 and Maureen Dubreuil4, 1Boston University, Boston, MA, 2VA Boston Healthcare System, Boston, MA, 3VA Boston Healthcare System, Boston University School of Medicine, Boston, MA, 4Department of Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: A meta-analysis demonstrated that the risk of vertebral fractures in Ankylosing Spondylitis (AS) is doubled compared to non-AS comparators. Increased fracture risk in AS…
  • Abstract Number: 1211 • ACR Convergence 2022

    Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of RA Patients

    Zhaohui Su1, Lauren Stevens2, Tom Brecht1, Jessica Paulus1 and Stefan Weiss3, 1OM1, Inc., Boston, MA, 2OM1, Inc., Lexington, KY, 3OM1, Inc., Chapel Hill, NC

    Background/Purpose: While many clinical trials provide direct comparisons between biologic disease modifying antirheumatic drugs (bDMARD) and nonbiologic DMARDs (nDMARD), there is a need to better…
  • Abstract Number: 1558 • ACR Convergence 2022

    Prevalence, Phenotypical Clinical Clusters and Treatment of Neurobehçet’s Disease: Study in Northern Spain

    Alba Herrero-Morant1, Carmen Alvarez Reguera2, Lara Sánchez-Bilbao2, David Martínez-López2, guillermo Suárez-Amorin2, Raúl fernández-ramón2, José Luis Martín-Varillas3, Cristina Mata4, Miguel Ángel González-Gay5 and Ricardo Blanco6, 1Hospital Universitario Marqués de Valdecilla, Ontinyent, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Hospital de Laredo, Laredo, Cantabria, Spain, 4Hospital Laredo, Santander, Spain, 5Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 6Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Behçet's disease (BD) may present with different clinical phenotypes. Ocular and Neurobehçet's Disease (NBD) are severe complications. Data on NBD epidemiology, clinical phenotype and…
  • Abstract Number: 1757 • ACR Convergence 2022

    The Independent Impact of Gout on Mortality and Risk of Coronary Heart Disease Among Women – a Prospective Cohort Analysis of Women over 34 Years

    Chio Yokose1, natalie mccormick1, na lu2, amit johi3, Gary Curhan4 and Hyon Choi5, 1Massachusetts General Hospital, Boston, MA, 2Arthritis Research Canada, Boston, MA, 3Regeneron, Boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: The disease burden of female gout has increased in recent years.1 However, there remains a paucity of data on female gout, despite it being…
  • Abstract Number: 1922 • ACR Convergence 2022

    Multi-Joint Osteoarthritis Phenotypes by Race/Ethnicity and Sex: Preliminary Descriptive Data from the Johnston County Health Study

    Sherwin Novin1, Carolina Alvarez2, Todd Schwartz3, Yvonne Golightly4 and Amanda Nelson2, 1University of North Carolina, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3University of North Carolina-Chapel Hill, Chapel Hill, NC, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: To describe phenotypes of multi-joint osteoarthritis (MJOA) definitions by race/ethnicity and sex in a community-based cohort.Methods: The Johnston County Health Study (JoCoHS) is an…
  • Abstract Number: 0070 • ACR Convergence 2022

    Post-operative Delirium and Cognitive Impairment: An Analysis of Predictors and 120-day Outcomes in England Using the National Hip Fracture Database (NHFD)

    Samuel Hawley1, Dominic Inman2, Celia Gregson1, Michael Whitehouse1, Antony Johansen3 and Andrew Judge1, 1University of Bristol, Bristol, United Kingdom, 2Northumbria Healthcare NHS Foundation Trust, Northumbria, United Kingdom, 3Cardiff University, Cardiff, Wales, United Kingdom

    Background/Purpose: Post-operative delirium and cognitive impairment are common after hip fracture. We set out to identify risk factors and examine the association with returning home…
  • Abstract Number: 0535 • ACR Convergence 2022

    Increase Rates of Bacterial Infection in Patients with ‘Pre-RA’

    Duncan Porter1, Sahil Jain2 and Fraser Morton3, 1Gartnavel General Hospital, Bearsden, United Kingdom, 2Gartnavel General Hospital, Glasgow, Scotland, United Kingdom, 3University of Glasgow, Glasgow, Scotland, United Kingdom

    Background/Purpose: In 'pre-RA' there is evidence of disordered immunity manifest by the presence of auto-antibodies, increased concentration of pro-inflammatory cytokines (e.g. TNF) and acute phase…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 55
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology